Wealthcare Advisory Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-4,997
Closed -$212K – 1481
2019
Q4
$212K Buy
4,997
+769
+18% +$30.5K 0.03% 290
2019
Q3
$162K Sell
4,228
-889
-17% -$34.2K 0.02% 308
2019
Q2
$199K Sell
5,117
-248
-5% -$9.42K 0.03% 270
2019
Q1
$213K Buy
5,365
+1,002
+23% +$39.6K 0.04% 233
2018
Q4
$159K Buy
4,363
+1,434
+49% +$56.4K 0.03% 239
2018
Q3
$125K Buy
2,929
+522
+22% +$21.2K 0.02% 294
2018
Q2
$93K Sell
2,407
-717
-23% -$26K 0.02% 337
2018
Q1
$109K Buy
3,124
+1,143
+58% +$40.7K 0.02% 263
2017
Q4
$72K Buy
+1,981
New +$71.6K 0.02% 314

Other funds holding BME

Wealthcare Advisory Partners's BME Position: Q1 2020 in Review

Wealthcare Advisory Partners sold out of BlackRock Health Sciences Trust (BME) in Q1 2020, closing a stake of 4,997 shares — an estimated $212K sold.

Wealthcare Advisory Partners first reported a position in BME in Q4 2017 and held it in 9 quarters. The position peaked at $213K in Q1 2019. 41 funds tracked by Wall St. Rank hold BME as of Q1 2020.

  • Wealthcare Advisory Partners reported no remaining BlackRock Health Sciences Trust position as of Q1 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 4,997 BlackRock Health Sciences Trust shares in Q1 2020, an estimated $212K.
  • Wealthcare Advisory Partners first reported a position in BlackRock Health Sciences Trust in Q4 2017 and held it in 9 quarters.
  • Wealthcare Advisory Partners's BlackRock Health Sciences Trust position peaked at $213K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2020, filed 29 Apr 2020.